C4 Therapeutics, Inc. - CCCC

SEC FilingsOur CCCC Tweets

About Gravity Analytica

Recent News

  • 05.07.2025 - C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
  • 05.07.2025 - C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
  • 03.03.2025 - TD Cowen 45th Annual Health Care Conference
  • 03.03.2025 - TD Cowen 45th Annual Health Care Conference
  • 02.27.2025 - C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
  • 02.27.2025 - C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
  • 02.24.2025 - C4 Therapeutics to Participate in Upcoming March Investor Conferences
  • 02.24.2025 - C4 Therapeutics to Participate in Upcoming March Investor Conferences

Recent Filings

  • 04.29.2025 - DEF 14A Other definitive proxy statements
  • 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.29.2025 - ARS Annual Report to Security Holders
  • 04.16.2025 - PRE 14A Other preliminary proxy statements
  • 04.14.2025 - 8-K Current report
  • 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 02.27.2025 - 8-K Current report
  • 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
  • 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans